Celldex Therapeutics (CLDX) Net Margin Growth (1y) (2011 - 2026)
Powered by 
Analysis
Celldex Therapeutics (CLDX) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | -185.00 |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | -763.00 |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | 529.00 |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | 4,168.00 |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 673.00 |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 2,208.00 |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | -392.00 |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 29,636.00 |
| 10 | Celldex Therapeutics | 3.08 Bn | 3.08 Bn | -2.57 Mn | -32.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -32.64 Mn |
| Mar 31, 2026 | -56.25 Mn |
| Dec 31, 2025 | -6.32 Mn |
| Jun 30, 2025 | -631,860.00 |
| Mar 31, 2025 | 1.33 Mn |
| Dec 31, 2024 | -296,019.00 |
| Sep 30, 2024 | 120,209.00 |
| Jun 30, 2024 | 994,652.00 |
| Mar 31, 2024 | -1.80 Mn |
| Dec 31, 2023 | 59,378.00 |
| Sep 30, 2023 | 405,875.00 |
| Jun 30, 2023 | 1.07 Mn |
| Mar 31, 2023 | 1.02 Mn |
| Dec 31, 2022 | 439,024.00 |
| Sep 30, 2022 | 678,648.00 |
| Jun 30, 2022 | -2.17 Mn |
| Mar 31, 2022 | -1.08 Mn |
| Dec 31, 2021 | -545,389.00 |
| Sep 30, 2021 | -1.12 Mn |
| Jun 30, 2021 | 428,987.00 |